350 related articles for article (PubMed ID: 19151727)
21. First Report of Concomitant Pathogenic Mutations Within MGC4607/CCM2 and KRIT1/CCM1 in a Familial Cerebral Cavernous Malformation Patient.
da Fontoura Galvão G; Veloso da Silva E; Fontes-Dantas FL; Filho RC; Alves-Leon S; Marcondes de Souza J
World Neurosurg; 2020 Oct; 142():481-486.e1. PubMed ID: 32615293
[TBL] [Abstract][Full Text] [Related]
22. Crystallographic Studies of the Cerebral Cavernous Malformations Proteins.
Fisher OS; Li X; Liu W; Zhang R; Boggon TJ
Methods Mol Biol; 2020; 2152():291-302. PubMed ID: 32524560
[TBL] [Abstract][Full Text] [Related]
23. Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation.
Tang AT; Sullivan KR; Hong CC; Goddard LM; Mahadevan A; Ren A; Pardo H; Peiper A; Griffin E; Tanes C; Mattei LM; Yang J; Li L; Mericko-Ishizuka P; Shen L; Hobson N; Girard R; Lightle R; Moore T; Shenkar R; Polster SP; Rödel CJ; Li N; Zhu Q; Whitehead KJ; Zheng X; Akers A; Morrison L; Kim H; Bittinger K; Lengner CJ; Schwaninger M; Velcich A; Augenlicht L; Abdelilah-Seyfried S; Min W; Marchuk DA; Awad IA; Kahn ML
Sci Transl Med; 2019 Nov; 11(520):. PubMed ID: 31776290
[TBL] [Abstract][Full Text] [Related]
24. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.
Akers AL; Johnson E; Steinberg GK; Zabramski JM; Marchuk DA
Hum Mol Genet; 2009 Mar; 18(5):919-30. PubMed ID: 19088123
[TBL] [Abstract][Full Text] [Related]
25. The structure of the ternary complex of Krev interaction trapped 1 (KRIT1) bound to both the Rap1 GTPase and the heart of glass (HEG1) cytoplasmic tail.
Gingras AR; Puzon-McLaughlin W; Ginsberg MH
J Biol Chem; 2013 Aug; 288(33):23639-49. PubMed ID: 23814056
[TBL] [Abstract][Full Text] [Related]
26. KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling.
DiStefano PV; Kuebel JM; Sarelius IH; Glading AJ
J Biol Chem; 2014 Nov; 289(47):33054-65. PubMed ID: 25320085
[TBL] [Abstract][Full Text] [Related]
27. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
28. Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.
Lopez-Ramirez MA; Pham A; Girard R; Wyseure T; Hale P; Yamashita A; Koskimäki J; Polster S; Saadat L; Romero IA; Esmon CT; Lagarrigue F; Awad IA; Mosnier LO; Ginsberg MH
Blood; 2019 Jan; 133(3):193-204. PubMed ID: 30442679
[TBL] [Abstract][Full Text] [Related]
29. Deletions in CCM2 are a common cause of cerebral cavernous malformations.
Liquori CL; Berg MJ; Squitieri F; Leedom TP; Ptacek L; Johnson EW; Marchuk DA
Am J Hum Genet; 2007 Jan; 80(1):69-75. PubMed ID: 17160895
[TBL] [Abstract][Full Text] [Related]
30. Novel CCM2 missense variants abrogating the CCM1-CCM2 interaction cause cerebral cavernous malformations.
Bergametti F; Viot G; Verny C; Brechard MP; Denier C; Labauge P; Petit P; Nouet A; Viallet F; Chaussenot A; Hervé D; Tournier-Lasserve E; Riant F
J Med Genet; 2020 Jun; 57(6):400-404. PubMed ID: 31937560
[TBL] [Abstract][Full Text] [Related]
31. Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.
Phillips CM; Stamatovic SM; Keep RF; Andjelkovic AV
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563390
[TBL] [Abstract][Full Text] [Related]
32. PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations.
Kar S; Samii A; Bertalanffy H
Neurosurg Rev; 2015 Apr; 38(2):229-36; discussion 236-7. PubMed ID: 25403688
[TBL] [Abstract][Full Text] [Related]
33. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.
Zawistowski JS; Stalheim L; Uhlik MT; Abell AN; Ancrile BB; Johnson GL; Marchuk DA
Hum Mol Genet; 2005 Sep; 14(17):2521-31. PubMed ID: 16037064
[TBL] [Abstract][Full Text] [Related]
34. A mechanism of Rap1-induced stabilization of endothelial cell--cell junctions.
Liu JJ; Stockton RA; Gingras AR; Ablooglu AJ; Han J; Bobkov AA; Ginsberg MH
Mol Biol Cell; 2011 Jul; 22(14):2509-19. PubMed ID: 21633110
[TBL] [Abstract][Full Text] [Related]
35. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
[TBL] [Abstract][Full Text] [Related]
36. Impaired retinoic acid signaling in cerebral cavernous malformations.
Grdseloff N; Boulday G; Rödel CJ; Otten C; Vannier DR; Cardoso C; Faurobert E; Dogra D; Tournier-Lasserve E; Abdelilah-Seyfried S
Sci Rep; 2023 Apr; 13(1):5572. PubMed ID: 37019926
[TBL] [Abstract][Full Text] [Related]
37. Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction.
Faurobert E; Albiges-Rizo C
FEBS J; 2010 Mar; 277(5):1084-96. PubMed ID: 20096036
[TBL] [Abstract][Full Text] [Related]
38. Lack of CCM1 induces hypersprouting and impairs response to flow.
Mleynek TM; Chan AC; Redd M; Gibson CC; Davis CT; Shi DS; Chen T; Carter KL; Ling J; Blanco R; Gerhardt H; Whitehead K; Li DY
Hum Mol Genet; 2014 Dec; 23(23):6223-34. PubMed ID: 24990152
[TBL] [Abstract][Full Text] [Related]
39. Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth.
Zheng X; Xu C; Smith AO; Stratman AN; Zou Z; Kleaveland B; Yuan L; Didiku C; Sen A; Liu X; Skuli N; Zaslavsky A; Chen M; Cheng L; Davis GE; Kahn ML
Dev Cell; 2012 Aug; 23(2):342-55. PubMed ID: 22898778
[TBL] [Abstract][Full Text] [Related]
40. The pathogenetic features of cerebral cavernous malformations: a comprehensive review with therapeutic implications.
Krisht KM; Whitehead KJ; Niazi T; Couldwell WT
Neurosurg Focus; 2010 Sep; 29(3):E2. PubMed ID: 20809760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
